NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Arch Coal (ACI) was upgraded at BMO Capital from underperform to market perform. $8 price target. Met coal fundamentals appear to be improving, BMO said.
Arotech (ARTX) upgraded to hold at TheStreet Ratings.First PacTrust Bancorp (BANC) upgraded to buy at TheStreet Ratings. BB&T (BBT) was upgraded at Bank of America/Merrill Lynch to buy. Stock is attractive, following a 15% pullback, BofA/Merrill said. $32 price target. Berry Plastics (BERY) was initiated with an outperform rating at Wells Fargo. Company offers innovative products and can pay down debt, Wells Fargo said. Bristol-Myers Squibb (BMY - Get Report) was downgraded at BMO Capital to market perform from outperform. $37 price target. A number of pipeline setbacks this year, BMO Capital said. Caterpillar (CAT - Get Report) was downgraded at JP Morgan from overweight to neutral. $90 price target. Company has high inventory levels and faces lower mining spending, JP Morgan said. Comerica (CMA - Get Report) was upgraded at Citigroup from sell to neutral. $28 price target. Stock is down 11% over the past seven months, Citi said. Disney (DIS - Get Report) was upgraded at Citi from neutral to buy. $54 price target. Recent acquisitions should boost future growth, Citi said. Garmin (GRMN) was downgraded at Goldman Sachs from neutral to sell. $34 price target. Company is seeing lower demand for personal navigation and fitness devices, Goldman said. Hibbett Sports (HIBB) was upgraded at Needham from hold to buy. Stock is down about 15% from its recent highs, Needham said. $61 price target. JC Penney (JCP) was downgraded at Credit Suisse from neutral to underperform. $15 price target. Estimates were also cut, as management is struggling to turn the business around, Credit Suisse said. Johnson & Johnson (JNJ) was downgraded at Jefferies to hold from buy. $75 price target. Easy money has been made, Jefferies said. Merck (MRK) was upgraded at BMO Capital to outperform from market perform. $50 price target. Positive data from two early-stage products, BMO Capital said. Nelnet (NNI) was upgraded at Credit Suisse from neutral to outperform. $33 price target. Estimates were also boosted, given loan purchases and higher realized net interest margin, Credit Suisse said. NYSE Euronext (NYX) was upgraded at Stifel Nicolaus from hold to buy. $27 price target. Stock is attractively valued at a 52-week low, Stifel Nicolaus said. Telephone & Data (TDS) was upgraded at Citigroup from neutral to buy. $27 price target. Management is selling assets while it is faced with with increased competition, Citi said. Tripadvisor (TRIP) was upgraded at Morgan Stanley from underweight to overweight. $41 price target. Company is changing its monetization strategy and remains leveraged to higher hotel shopper growth, Morgan Stanley said. US Cellular (USM) was upgraded at Citigroup from neutral to buy. $42 price target. Wireless asset purchase should be accretive to shareholder value, Citi said. Vertex Pharmaceuticals (VRTX) was downgraded at Credit Suisse from outperform to neutral. $48 price target. Company will likely see lower Incivek sales, Credit Suisse said. Western Union (WU) was upgraded at DA Davidson to neutral from underperform. $13 price target. At current prices, downside appears minimal, DA Davidson said.